Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G R Matzke

Showing results (81-90 of 124) with videos related to

Pageof 13
Sort By:
Antimicrobial Agents and Chemotherapy|July 1, 1986
Disposition of cefotaxime and desacetyl cefotaxime during continuous ambulatory peritoneal dialysisK L Heim, C E Halstenson, C M Comty, et al.
American Journal of Nephrology|January 1, 1985
Protein binding of disopyramide and elevated alpha-1-acid glycoprotein concentrations in serum obtained from dialysis patients and renal transplant recipientsD B Haughey, C J Kraft, G R Matzke, et al.
Transplantation|June 1, 1987
Effects of cyclosporine on the isolated perfused rat kidneyD R Luke, B L Kasiske, G R Matzke, et al.
The Annals of Pharmacotherapy|April 9, 1998
A primer on continuous renal replacement therapy for critically ill patientsM S Joy, G R Matzke, D K Armstrong, et al.
American Journal of Nephrology|January 1, 1988
Suprofen-induced uricosuria. A potential mechanism for acute nephropathy and flank painP A Abraham, C E Halstenson, J A Opsahl, et al.
Therapeutic Drug Monitoring|June 1, 1992
Bioavailability of labetalol in patients with end-stage renal diseaseD R Luke, W M Awni, C E Halstenson, et al.
British Journal of Clinical Pharmacology|September 1, 1996
The effect of age on the pharmacokinetics of the opioid antagonist nalmefeneR F Frye, G R Matzke, N S Jallad, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 1, 1987
Systemic absorption of oral vancomycin in patients with renal insufficiency and antibiotic-associated colitisG R Matzke, C E Halstenson, P L Olson, et al.
Journal of Clinical Pharmacology|April 1, 1991
Pharmacokinetics of cefprozil in healthy subjects and patients with renal impairmentW C Shyu, K A Pittman, R B Wilber, et al.
Pharmacotherapy|September 1, 1985
Antihypertensive therapy with once-daily administration of terazosin, a new alpha 1-adrenergic-receptor blockerP A Abraham, C E Halstenson, G R Matzke, et al.
Pageof 13

Showing results (81-90 of 124) with videos related to

Sort By:
Pageof 13
Antimicrobial Agents and Chemotherapy|July 1, 1986
Disposition of cefotaxime and desacetyl cefotaxime during continuous ambulatory peritoneal dialysisK L Heim, C E Halstenson, C M Comty, et al.
American Journal of Nephrology|January 1, 1985
Protein binding of disopyramide and elevated alpha-1-acid glycoprotein concentrations in serum obtained from dialysis patients and renal transplant recipientsD B Haughey, C J Kraft, G R Matzke, et al.
Transplantation|June 1, 1987
Effects of cyclosporine on the isolated perfused rat kidneyD R Luke, B L Kasiske, G R Matzke, et al.
The Annals of Pharmacotherapy|April 9, 1998
A primer on continuous renal replacement therapy for critically ill patientsM S Joy, G R Matzke, D K Armstrong, et al.
American Journal of Nephrology|January 1, 1988
Suprofen-induced uricosuria. A potential mechanism for acute nephropathy and flank painP A Abraham, C E Halstenson, J A Opsahl, et al.
Therapeutic Drug Monitoring|June 1, 1992
Bioavailability of labetalol in patients with end-stage renal diseaseD R Luke, W M Awni, C E Halstenson, et al.
British Journal of Clinical Pharmacology|September 1, 1996
The effect of age on the pharmacokinetics of the opioid antagonist nalmefeneR F Frye, G R Matzke, N S Jallad, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 1, 1987
Systemic absorption of oral vancomycin in patients with renal insufficiency and antibiotic-associated colitisG R Matzke, C E Halstenson, P L Olson, et al.
Journal of Clinical Pharmacology|April 1, 1991
Pharmacokinetics of cefprozil in healthy subjects and patients with renal impairmentW C Shyu, K A Pittman, R B Wilber, et al.
Pharmacotherapy|September 1, 1985
Antihypertensive therapy with once-daily administration of terazosin, a new alpha 1-adrenergic-receptor blockerP A Abraham, C E Halstenson, G R Matzke, et al.
Pageof 13